# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001819790-21-000027
Filing Date
2021-08-05
Accepted
2021-08-04 17:40:28
Documents
57
Period of Report
2021-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | tars-20210630.htm iXBRL | 10-Q | 1107949
2 | EX-31.1 | exhibit31111.htm | EX-31.1 | 11875
3 | EX-31.2 | exhibit31211.htm | EX-31.2 | 12131
4 | EX-32.1 | exhibit32111.htm | EX-32.1 | 9962
5 | EX-32.2 | exhibit32211.htm | EX-32.2 | 9904
| Complete submission text file | 0001819790-21-000027.txt |  | 5094218

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | tars-20210630.xsd | EX-101.SCH | 31438
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | tars-20210630_cal.xml | EX-101.CAL | 63111
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | tars-20210630_def.xml | EX-101.DEF | 134309
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | tars-20210630_lab.xml | EX-101.LAB | 426941
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | tars-20210630_pre.xml | EX-101.PRE | 271591
11 | EXTRACTED XBRL INSTANCE DOCUMENT | tars-20210630_htm.xml | XML | 824017

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Filer) CIK: 0001819790 (see all company filings)

EIN.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39614 | Film No.: 211145350
SIC: 2836 Biological Products, (No Diagnostic Substances)